New York City, NY (PRWEB) October 03, 2012
On October 3, 2012, nonprofit organization, Voices Against Brain Cancer (VABC), released a statement following reports that researchers had made what could be a breakthrough in the treatment of deadly brain tumors.
According to eScienceNews.com, “In what could be a breakthrough in the treatment of deadly brain tumors, a team of researchers from Barrow Neurological Institute and Arizona State University has discovered that the immune system reacts differently to different types of brain tissue, shedding light on why cancerous brain tumors are so difficult to treat.”
The article goes on to quote Dr. Mark Preul, who stated, “This is the first time that researchers have conducted a regional tissue study of the brain and a malignant glioma to show that these immune cells do not aggregate or behave in the same way in their respective areas of the brain. This means that effective treatment in one area of the brain may not be effective in another area. In fact, it could even cause other regions of the tumor to become worse.”
VABC representative, Clay Darrohn, states, “We believe that research like this is essential in the battle against brain cancer. The more that we know about this devastating disease, from cause to treatment, the more we can do to help provide answers and effective treatment for those diagnosed.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.